Home/Health And Wellness/

Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says

Jonny Smith Reply 03:31 A+ A-

Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says

Novavax announced on Monday that its COVID-19 vaccine was found to be over 90% effective overall, and offered 100% protection against moderate and severe disease in a Phase 3 clinical trial.

Health And Wellness, Health Blogs, Health Care, Health Drinks, Health Drinks for Kids, Health is Wealth, Health Tips

Post a Comment

:noprob:

:smile:

:shy:

:trope:

:sneered:

:happy:

:escort:

:rapt:

:love:

:heart:

:angry:

:hate:

:sad:

:sigh:

:disappointed:

:cry:

:fear:

:surprise:

:unbelieve:

:shit:

:like:

:dislike:

:clap:

:cuff:

:fist:

:ok:

:file:

:link:

:place:

:contact:

Newer PostAs COVID-19 cases wane, vaccine-lagging areas still see risk

Older PostMinoxidil reported to cause visual problems

Copyright (c) 2018 Healthell - Daily Viral Health News.